Oligomeric compounds having at least one neutrally linked terminal bicyclic nucleoside
    31.
    发明授权
    Oligomeric compounds having at least one neutrally linked terminal bicyclic nucleoside 有权
    具有至少一个中性连接的末端双环核苷的低聚化合物

    公开(公告)号:US09290534B2

    公开(公告)日:2016-03-22

    申请号:US12934498

    申请日:2009-04-03

    IPC分类号: C07H21/00

    CPC分类号: C07H21/00

    摘要: The present disclosure describes oligomeric compounds having at least one bicyclic nucleoside attached to the 3′ or 5′ termini by a neutral internucleoside linkage and methods of using the oligomeric compounds. In some embodiments, the oligomeric compounds provided herein hybridize to a portion of a target RNA resulting in loss of normal function of the target RNA.

    摘要翻译: 本公开内容描述了通过中性核苷间键连接至3'或5'末端的至少一个双环核苷的低聚化合物和使用寡聚化合物的方法。 在一些实施方案中,本文提供的寡聚化合物与靶RNA的一部分杂交,导致靶RNA的正常功能丧失。

    SELECTIVE ANTISENSE COMPOUNDS AND USES THEREOF
    36.
    发明申请
    SELECTIVE ANTISENSE COMPOUNDS AND USES THEREOF 审中-公开
    选择性抗体化合物及其用途

    公开(公告)号:US20150051389A1

    公开(公告)日:2015-02-19

    申请号:US14238439

    申请日:2012-08-08

    IPC分类号: C12N15/113

    摘要: Disclosed are oligomeric compounds which are useful for hybridizing to a complementary nucleic acid, including but not limited, to nucleic acids in a cell. The hybridization results in modulation of the amount activity or expression of the target nucleic acid in a cell.

    摘要翻译: 公开了可用于与互补核酸杂交(包括但不限于细胞中的核酸)的寡聚化合物。 杂交导致细胞中靶核酸的量活性或表达的调节。

    LINKAGE MODIFIED GAPPED OLIGOMERIC COMPOUNDS AND USES THEREOF
    38.
    发明申请
    LINKAGE MODIFIED GAPPED OLIGOMERIC COMPOUNDS AND USES THEREOF 审中-公开
    链接修饰的低分子化合物及其用途

    公开(公告)号:US20140303235A1

    公开(公告)日:2014-10-09

    申请号:US14237967

    申请日:2012-08-08

    IPC分类号: C12N15/113

    摘要: The present invention provides gapped oligomeric compounds. More particularly the gapped oligomeric compounds provided herein comprise at least one modified intemucleoside linkage in the gap region. Such gapped oligomeric compounds have one or more improved properties such as selectivity, potency, improved toxicity profile and or improved proinflammatory profile. Certain such oligomeric compounds are useful for hybridizing to a complementary nucleic acid, including but not limited, to nucleic acids in a cell. In certain embodiments, hybridization results in modulation of the amount activity or expression of the target nucleic acid in a cell.

    摘要翻译: 本发明提供了有效的寡聚化合物。 更具体地,本文提供的有间隙的寡聚化合物在间隙区域中包含至少一个修饰的核苷间键。 这种有效的低聚化合物具有一个或多个改进的性质,例如选择性,效力,改善的毒性特征和/或改善的促炎症状。 某些这样的寡聚化合物可用于与互补核酸杂交,包括但不限于细胞中的核酸。 在某些实施方案中,杂交导致细胞中靶核酸的活性或表达的调节。